dobutamine has been researched along with fenoldopam in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carey, RA; Jacob, L | 1 |
| Ruffolo, RR; Shebuski, RJ; Smith, JM | 1 |
| Glock, D; Goldberg, LI; Lass, NA | 1 |
| Jacinto, SM; Jandhyala, BS; Lokhandwala, MF | 1 |
| Jacinto, SM; Jandhyala, BS | 1 |
| Coluzzi, F; Conti, G; De Gaetano, A; Morelli, A; Orecchioni, A; Pelaia, P; Pietropaoli, P; Rocco, M; Vernaglione, E | 1 |
2 review(s) available for dobutamine and fenoldopam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
1 trial(s) available for dobutamine and fenoldopam
| Article | Year |
|---|---|
Effects of short-term fenoldopam infusion on gastric mucosal blood flow in septic shock.
Topics: Adrenergic beta-Agonists; Critical Care; Dobutamine; Double-Blind Method; Female; Fenoldopam; Gastric Acidity Determination; Gastric Mucosa; Hemodynamics; Humans; Infusions, Intravenous; Laser-Doppler Flowmetry; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Regional Blood Flow; Shock, Septic; Vasoconstrictor Agents; Vasodilator Agents | 2004 |
5 other study(ies) available for dobutamine and fenoldopam
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dog.
Topics: Animals; Benzazepines; Cardiotonic Agents; Dobutamine; Dogs; Dopamine; Female; Fenoldopam; Heart Failure; Humans; Male; Norepinephrine; Pulmonary Circulation; Renal Circulation; Vascular Resistance | 1988 |
Cardiovascular and renal hemodynamic effects of intravenous infusions of the selective DA1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Blood Pressure; Dobutamine; Dogs; Dopamine; Fenoldopam; Infusions, Intravenous; Myocardial Contraction; Phenoxybenzamine; Renal Circulation; Vascular Resistance | 1988 |
Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist.
Topics: Adrenergic Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Blood Pressure; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Rate; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Dopamine D1 | 1994 |
Salutary effects of dopexamine, a DA-1 and beta-2 agonist, on free radical-induced toxicity in anesthetized rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic beta-Agonists; Animals; Blood Pressure; Dobutamine; Dopamine; Fenoldopam; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Dopamine; Superoxide Dismutase; Xanthine; Xanthine Oxidase; Xanthines | 1994 |